Brief: Enanta Pharmaceuticals Reports Q3 Loss Per Share $1.53

Enanta Pharmaceuticals

08/08/2022 23:17

Aug 8 (Reuters) - Enanta Pharmaceuticals Inc  ENTA.O :
    * Q3 LOSS PER SHARE $1.53
    * QTRLY TOTAL REVENUE OF $19.5 MILLION VERSUS $21.6 MILLION
    * Q4 EARNINGS PER SHARE VIEW $-1.27, REVENUE VIEW $23.5
MILLION --
REFINITIV IBES DATA
    * Q3 EARNINGS PER SHARE VIEW $-1.39, REVENUE VIEW $20.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBwcg38vTa 
Further company coverage:  ENTA.O 

 ((Reuters.Briefs@thomsonreuters.com;))